Case report: A Chinese patient with glutathione synthetase deficiency and a novel glutathione synthase mutation

Glutathione synthetase deficiency (GSSD) is an autosomal-recessive metabolic disorder caused by glutathione synthetase (GSS) gene mutations. No more than 90 cases of GSSD have been reported worldwide; thus, the spectrum of GSS mutations and the genotype-phenotype association remain unclear. Here, we...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaojiao Wu (Author), Jiancheng Jiao (Author), Yaofang Xia (Author), Xiaotong Yan (Author), Zehao Liu (Author), Yanyan Cao (Author), Li Ma (Author)
Format: Book
Published: Frontiers Media S.A., 2023-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_310392364a514a839f19911f3048ad8d
042 |a dc 
100 1 0 |a Xiaojiao Wu  |e author 
700 1 0 |a Xiaojiao Wu  |e author 
700 1 0 |a Jiancheng Jiao  |e author 
700 1 0 |a Jiancheng Jiao  |e author 
700 1 0 |a Yaofang Xia  |e author 
700 1 0 |a Yaofang Xia  |e author 
700 1 0 |a Xiaotong Yan  |e author 
700 1 0 |a Xiaotong Yan  |e author 
700 1 0 |a Zehao Liu  |e author 
700 1 0 |a Zehao Liu  |e author 
700 1 0 |a Yanyan Cao  |e author 
700 1 0 |a Yanyan Cao  |e author 
700 1 0 |a Li Ma  |e author 
700 1 0 |a Li Ma  |e author 
245 0 0 |a Case report: A Chinese patient with glutathione synthetase deficiency and a novel glutathione synthase mutation 
260 |b Frontiers Media S.A.,   |c 2023-07-01T00:00:00Z. 
500 |a 2296-2360 
500 |a 10.3389/fped.2023.1212405 
520 |a Glutathione synthetase deficiency (GSSD) is an autosomal-recessive metabolic disorder caused by glutathione synthetase (GSS) gene mutations. No more than 90 cases of GSSD have been reported worldwide; thus, the spectrum of GSS mutations and the genotype-phenotype association remain unclear. Here, we present a severely affected infant carrying a compound heterozygous GSS variation, c.491G > A, and a novel variant of c.1343_1348delTACTTC. We also summarize the clinical manifestations, treatment protocol, prognosis, and genetic characteristics of previously reported GSSD cases in China. In this case study, our patient presented with tachypnea, jaundice, intractable metabolic acidosis, and hemolytic anemia. Urinary-organic acid analysis revealed elevated 5-oxoproline levels. Further, this patient showed improved outcomes owing to early diagnosis and the timely administration of vitamins C and E. Therefore, our study indicates that in clinical cases of unexplained hemolytic anemia and metabolic acidosis, GSSD should be considered. Additionally, genetic testing and antioxidant application might help identify GSSD and improve the prognosis. 
546 |a EN 
690 |a glutathione synthetase deficiency 
690 |a 5-oxoprolinuria 
690 |a glutathione synthetase gene variation 
690 |a newborn 
690 |a inherited metabolic disease 
690 |a case report 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pediatrics, Vol 11 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fped.2023.1212405/full 
787 0 |n https://doaj.org/toc/2296-2360 
856 4 1 |u https://doaj.org/article/310392364a514a839f19911f3048ad8d  |z Connect to this object online.